ESR2 and Alzheimer disease: In the present study, selective activation of ERβ in the AppNL−G−F model, not only confirms previous studies in older AD transgenic models on ERβ’s protective effects [9, 11, 30, 31], but also identifies important new sex differences in ERβ mediated protection.